We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Scientists hail ‘entirely novel approach’ to controlling a disease that kills more than 600,000 a year
Legal and regulatory actions are more likely to drag on earnings than negate them
Novo Nordisk and Eli Lilly accused of failing to warn patients of gastroparesis risk
Chemify’s technology aims to remove bottleneck of producing molecules in the lab
Prevention strategies close to wiping out transmission in parts of city that were once epicentre of Australia’s Aids epidemic
Efforts by ProMED to raise money from public sector and philanthropists fall short of target
Move by RMT, Unite and Aslef comes as stoppage by top NHS doctors in England ends without resolution
A doctor, a model and a boxer raised millions from Covid sceptics and anti-vaxxers. Then a knock-down, drag-out brawl broke out
Dementia experts hail ‘watershed moment’ after trial results for donanemab antibody treatment
UK health security agency says low vaccination rates make capital vulnerable to a damaging outbreak
Healthcare needs a productivity revolution but not at the expense of patient privacy and safety
Manipulation of brain signals advancing so fast it threatens human rights, warns UN body
Medicines produced by pharma group will be for domestic use only
A decade ago a large part of Big Pharma gave up on one of humanity’s cruellest diseases. But then a new treatment showed promise
Successful pilot in England will be expanded to more pharma companies and include N Ireland, Scotland and Wales
New treatments have had remarkable results but there are reasons to be cautious
Large-scale study will test GSK’s jab in 26,000 people in Africa and south-east Asia
Former health secretary tells Covid inquiry the country should have focused more on halting disease transmission
New research suggests a daytime sleep can delay neurodegeneration, but what about those who just can’t?
Well-prepped countries have fared no better in the past. But there are ways to adapt
Ministers must make tough spending choices on preparedness between pandemics, warn Whitty and Vallance
Ministers say ‘groupthink’ meant they were persuaded Britain was one of best prepared nations before Covid-19 struck
These tapestries of tissue could shed light on infertility and pregnancy loss — but updated regulation is essential
Former Tory PM admits ‘consequences’ resulted from decision to focus less on other diseases
FDA considers clearing a treatment for Duchenne muscular dystrophy despite lack of ‘unambiguous evidence’ it works
UK Edition